Skip to main content
PLOS One logoLink to PLOS One
. 2024 Dec 18;19(12):e0314629. doi: 10.1371/journal.pone.0314629

Paw pressure and gait in middle-aged client-owned cats with and without naturally-occurring musculoskeletal disease

Nathalie Dowgray 1,2,*, Eithne Comerford 1,3,4, Alexander J German 1,3, James Gardiner 1,¤, Gina Pinchbeck 5, Karl T Bates 1
Editor: Antal Nógrádi6
PMCID: PMC11654939  PMID: 39693355

Abstract

Musculoskeletal disease (MSD) is common in ageing cats, resulting in chronic pain and mobility impairment, but diagnosis can be challenging. We hypothesised that there would be differences between cats with and without MSD in paw pressure and spatiotemporal and kinetic gait metrics. A cohort of 53 cats, aged between 7 and 10 years from the North West of the United Kingdom, underwent an orthopaedic examination and walked on a pressure sensitive walkway. Thirty-one of the cats (58%) were determined to be apparently-healthy, based on a normal orthopaedic examination and having no history of MSD, whilst the remaining 22 cats (42%) had findings consistent with MSD; 13/22 cats (59%) had multiple limb involvement, 7/22 (32%) had forelimb involvement and 2/22 (9%) had hindlimb involvement. Bodyweight (P = 0.048) and body condition score (BCS; P = 0.015) were both greater in cats with MSD (mean bodyweight 5.4 ± 1.35 kg; median BCS 6, IQR 6–7.75) compared with apparently-healthy cats (mean bodyweight 4.7 ± 0.94 kg; median BCS 5, IQR 4.5–6.5). There was a relatively large intra-cat variation in spatiotemporal and kinetic gait variables (coefficient of variation >3.0%), whilst a linear mixed-effects model suggested no significant difference in spatiotemporal or kinetic gait variables between apparently-healthy cats and those with MSD. Palmar and plantar pressure asymmetry was assessed by pedobarographic statistical parametric mapping (pSPM) within each individual cat, with no significant difference (P = 0.353) between the apparently heathy cats and those with MSD as to the presence or absence of asymmetry. Given the marked intra-cat variation and the ‘multi-limb’ nature of MSD in this cohort, it was not possible to differentiate healthy cats from those with MSD based on spatiotemporal and kinetic gait metrics or paw pressure asymmetry. Future work should examine gait in cats with defined musculoskeletal disorders (e.g. hip dysplasia) and also to track longitudinal changes within individual cats to better establish age-related trends.

Introduction

Musculoskeletal disease (MSD) is common in ageing cats, with degenerative joint disease (DJD), encompassing osteoarthritis (OA), being most prevalent [1], albeit depending on the methodology of the study and the population assessed [2]. Radiographic studies have estimated the prevalence of DJD for cats to be between 22% and 92% [37]; in contrast, a prevalence of only 2% was suggested in a study using non-radiographic data from primary care veterinary practices [8]. These differences highlight the difficulty in diagnosing feline DJD in clinical practice and suggest significant under-reporting.

Diagnosis of MSD in cats is commonly made using a combination of owner-observed changes, veterinary orthopaedic examination findings and radiography [9]. Although owner-observed changes in mobility, activity, grooming, temperament and response to analgesia can be useful in assessing chronic pain caused by DJD [7, 1012], such observations are subjective. Feline DJD-specific clinical metrology instruments have been created to standardise these subjective measures [1215], although limitations remain including the tendency for responses to be overestimated when they are used as the sole outcome measure [16]. Therefore, there is a need for more objective measures to improve the diagnosis of age-related MSD in cats such as gait analysis as used in other species [1719].

Normal feline gait in healthy cats has been investigated with pressure-sensitive walkways, which measure paw pressure, vertical ground reaction forces and spatiotemporal gait kinematics [2025]. Gait analysis has also been used to assess parameters in cats post-onychectomy; in cats with coxofemoral OA and stifle OA following cranial cruciate injury; in cats that have undergone femoral head and neck ostectomy; and also to detect hindlimb lameness [2630]. Furthermore, gait metrics have been used to quantify post-operative lameness due to different surgical techniques [31], and also the effect of analgesia in post-surgical models [32] and naturally occurring OA [33]. A limitation of all these studies is that only cats with either a single condition or unilateral disease have been studied; since feline DJD is often bilateral, affecting multiple limbs and joints, the effects on gait, including any asymmetry are likely to be more complex [6, 7]. Given the limited information currently available, the aim of the current study was to use a pressure-sensitive walkway to measure gait metrics in senior pet cats with and without MSD. We hypothesised that cats with and without MSD would differ in paw pressure and spatiotemporal and kinetic gait metrics.

Materials and methods

Eligibility criteria

Client owned cats that had been enrolled in the Cat Prospective Ageing and Welfare Study (CatPAWS), between 2017 and 2020 and meeting all recruitment and eligibility criteria [34], were eligible for participation. Ethical approval for CatPAWS was granted by the University of Liverpool Veterinary Research Ethics committee (VREC491abcd). Briefly, the cats needed to be between 7 and 10 years of age and owners had to consent to visit the Feline Healthy Ageing Clinic, University of Liverpool, UK (the data collection clinic for CatPAWS) every six months. Additional eligibility criteria for the current study were that the enrolled cats had to have had an orthopaedic examination performed, and have completed two or more successful crossings of a pressure-sensitive walkway (see below) at either their enrolment or first annual appointment. A successful crossing was defined as the cat passing the whole length of the walkway in a straight line, at a continuous walk (<1m/s) with the head facing forward during the entire crossing [23].

Examination for MSD

As part of their involvement in the CatPAWS study, all cats received regular clinical assessments with a qualified veterinarian and registered veterinary nurse, including bodyweight measurement, body condition scoring (BCS) and an orthopaedic examination performed by the veterinarian and based on previously-published criteria [35]. The orthopaedic examination included a visual assessment on cats’ willingness to walk around the consultation room [9, 36] and an assessment of coat condition and grooming activity [7, 10]. Each cat was also assessed for muscular asymmetry, the vertebral column was palpated for evidence of pain, and range of movement (ROM) of the neck and tail was also checked. On a limb-by-limb basis, the digits were examined for thickening of the claws and evidence of pain on manipulation; then, working up the limb, the appendicular joints (carpus, elbow, shoulder, tarsus, stifle and coxofemoral) were palpated for thickening, ROM and pain. Pain assessment was based on previously-published systems and classified as follows: ‘no resentment’, ‘tries to escape/prevent manipulation’, ‘bite/hiss’, ‘marked guarding of area’ [35]. Thickening of joints was recorded as ‘normal’, ‘mild-to-moderate’ or ‘severe’, whilst ROM was recorded as ‘normal’, ‘reduced’ or ‘cannot manipulate’ [35]. The cats were held with gentle restraint throughout the examination and a temperament assessment was recorded at the end [35].

Cats were defined as ‘apparently-healthy middle-aged cats’ if they had no history of MSD and had no discernible issues on their orthopaedic examination. Cats were classified as ‘having MSD’ if they had a history of a disease involving the orthopaedic system, such as DJD, a femoral head and neck excision or a previous fracture, or findings consistent with MSD on their orthopaedic examination, including: pain upon joint manipulation, joint thickening, joint effusion and a reduction in the ROM of the joint [35, 37]. For analysis of paw pressure and spatiotemporal and kinetic gait metrics, cats in the MSD group were assigned to sub-groups based on the limb(s) affected. Additionally, all cats’ limbs were labelled as healthy or not healthy for assessment (e.g., all apparently healthy cats recorded four healthy limbs, whilst the MSD group could have one or more non healthy limbs.).

Gait analysis

A pressure-sensitive walkway, measuring 0.45m by 1.76m, was used for gait analysis (HRV3 High resolution walkway system, Tekscan, USA). Spatial resolution for this walkway was 3.9 sensel per cm2 and the frame rate was set at 100 frames per second [38]. A modified, clear poly-tunnel was placed over the walkway to encourage cats to move in a straight line (Fig 1). Cats were encouraged to walk at their own pace across the walkway, either using positive reinforcement (food treats, verbal praise, stroking or grooming) or by providing access to a hiding place at the end of the tunnel (basket or cat hide). Each crossing was filmed using a digital camera (Panasonic Lumix DMC-TZ6) positioned perpendicular to the pressure mat.

Fig 1. Layout of the consultation room showing the pressure-sensitive walkway with the polytunnel.

Fig 1

The digital camera (Panasonic Lumix DMC-TZ6) used for filming was positioned on the middle shelf of the laptop stand (obscured from view in the photograph by the consulting room examination table) perpendicular to the direction of travel, providing a lateral view of the cat’s gait.

At the start of each weekly session, the pressure-sensitive walkway was calibrated, involving the creation of a calibration file, which was then used for all sessions over the following 2–3 days [38]. Each of the 3 walkway sections was calibrated with an object of known weight (usually a bag of canine dry food or a plastic container containing cat litter, typical weight 10–16 kg), as per manufacturer recommendations (Tekscan). This calibration method was used for data collected between February 2017 and May 2019. However, interim data analysis revealed that paw pressure readings were greater than expected in some cats; after discussion with the manufacturer, a three-legged stool loaded with 10kg of weight plates (10.9 kg in total) was instead used for calibration, enabling pressure to be focused over three small areas, thereby mimicking the pressure generated by a feline paw [22, 39]. To enable analysis of all data, files collected between February 2017 and May 2019 were retrospectively calibrated using a stool calibration file created in June 2019. Analysis of retrospectively-calibrated longitudinal data showed that, over a two-year period there was also a decline in the sensitivity of the pressure-sensitive walkway, which could have been adjusted for using contemporaneous calibration but not by using retrospective calibration. Since the cycle time, impulse and bodyweight of the cat (mass) were all known, a calibration factor was created and applied to the ground reaction forces for analysis, as follows:

Calibration factor = (Total impulse (Ns)/Cycle time (sec))/Cat’s mass (N) [38]

Gait parameters were extracted for each gait cycle using the software (‘Walkway Research’, version 7.66–03, Tekscan, USA) and those assessed for each limb are summarised in Table 1. Duty factor (stance time/stride time), normalised peak vertical force (PVF) and normalised vertical impulse (VI) were calculated. Normalised ground reaction forces were calculated by dividing the peak forces by the cat’s bodyweight in Newtons. Fore- and hindlimb symmetry indices were calculated for duty factor (DF), PVF and VI as previously described [24, 25, 29, 30], where 0% represents perfect symmetry.

Table 1. Spatiotemporal and kinetic parameters extracted for each gait cycle and assessed for each limb.

Spatiotemporal parameters
Variable Description Unit
Stance time Time from first contact to last contact of each paw seconds
Swing time Time between last contact of proceeding and next contact of two consecutive paw falls seconds
Stride length Distance between two posterior points of consecutive paw falls metres
Stride velocity Stride length divided by the stride time for each limb metres/second
Duty factor (DF) Percentage of time per cycle the paw spends on the ground in each limb cycle, calculated by dividing the stance time by the stride time %
Velocity Gait distance divided by the gait time metres/second
Gait cycle time Time to complete one gait cycle (second) seconds
Kinetic parameters
Variable Description
Maximum PVF Maximum force during the stance of the foot Newton
Normalised PVF PVF / Bodyweight in Newtons percentage
Maximum VI Area under the force time curve for the duration of the stance Newton seconds
Normalised VI VI / Bodyweight in Newtons percentage

Data collected using the software ‘Walkway Research’, version 7.66–03, Tekscan, USA. DF = Duty Factor, PVF = Peak Vertical force, VI = Vertical impulse

Pressure data for each crossing were exported as a comma-separated value files (.csv) and analysed using tools from the suite of pedobarographic statistical parametric mapping (pSPM) functions within MATLAB (Version 9.6, MathWorks ®, Natick, Massachusetts, USA) [40, 41]. Peak pressure data were extracted, and peak pressure images (p-images) created and labelled (left forelimb [LF]; right forelimb [RF)]; left hindlimb [LH]; right hindlimb [RH]) for each crossing, resulting in the production of 2–3 p-images per limb. Left peak pressure images were flipped on a vertical axis, to enable direct comparisons to be made with right p-images. All p-images, for each cat and paw, were registered to each other in a vertical stack using a two-stage, rigid-body transformation via an algorithm that aimed to minimise the between-image mean square error and ensuring optimal overlap of homologous structures [4042]. In this respect, the first print for each paw was initially used as a template, with all other prints aligned to this. Following alignment, a mean pressure record was created and used as the basis for a second registration [4042]. In contrast to human foot pressure records, on which this process has been extensively tested [4048], cat prints were round; as a result, all final images were visually assessed to ensure that cranial-caudal alignment on the vertical axis was maintained in the final mean image. To achieve this, the mean image was aligned against a grid of equivalent size to the pixels of the pressure-sensitive walkways, enabling fine manual adjustments to be made if required. Any such adjustments were applied to the p-image stack resulting in the creation of a new aligned mean. Once completed, a mean peak pressure p-image was created for each limb of each cat using their individual peak pressure records, the total number of p-images per cat limb is the p-image stack denominator.

Statistical analysis

Statistical analysis was performed using an online statistical environment and language (R, version 4.0.0 [49]) with several additional packages as explained below. Gait parameters were first assessed for normality using histograms, Q-Q plots and the Shapiro-Wilk test. Frequencies were reported as numbers and percentages, normally-distributed data were described using mean, standard deviation (SD), minimum (min) and maximum (max); data that were not normally-distributed were instead described using median and inter-quartile range (IQR). Parametric tests were used for normally-distributed data and non-parametric tests used where data were not normally distributed. The level of assumed statistical significance was P<0.05.

Individual cat analysis

The following additional R packages were used in analyses using data from individual cats:”ggplot version 2 3.3.6” [50], “ggpubr version 0.4.0” [51] and “reshape version 0.8.9” [52]. Descriptive statistics, as described above, were created for all successful crossings from each cat. The PVF and VI distribution within each cat across all limbs were assessed by analysis of variance (ANOVA). These data were then compared with the clinical data (MSD status and orthopaedic examination findings) to determine if any relationship was present, for example asymmetry. As this exercise was for data visualisation only, P-values were not corrected for multiple comparisons. Between-group distribution was assessed using Fisher’s exact test.

Asymmetry in peak pressure distribution was assessed by comparing p-images between LF and RF, and also between LH and RH, using topological t-tests from the pSPM suite in MATLAB [4042, 46]. In traditional analytical approaches, statistical tests are typically conducted on single pressure values extracted from either discrete anatomical regions (e.g. mean or maximum ‘heel’ pressure) or the entire pressure record (e.g. mean or maximum pressure). However, in pSPM, data from the paw pressure records are smooth and continuous, with neighbouring pixels in pressure images being were neither biologically nor statistically independent [4042, 46]. To address this, pSPM generates a continuous statistical map across the entire pressure record, with random field theory then used to conduct inference topologically, based on the height and size of connected clusters of pixels in the image that remained following suitably high SPM thresholding [53]. The final output, therefore, was the identification of individual or clusters of pixels that significantly differed in two samples of pressure images, and accounting for their two-dimensional topological characteristics. The two-sample students t-test was performed with the aligned image stacks to examine differences in pressure between a pixel and the surrounding pixels [41]. The presence or absence of left-right mean peak pressure asymmetry was determined for each individual cat, and this was then assessed between groups using Fisher’s exact test, whilst Wilcoxon’s signed ranks test was used to assess the effect of p-image stack denominator on determination of asymmetry.

The coefficient of variation (CV) was used to examine individual cat variation [24]; within-cat CV was calculated for all the gait parameters for each session, with a CV ≤ 3% considered to be ‘low variability’ [42, 54, 55].

Comparing gait parameters in apparently-healthy middle-aged cats and those with MSD

The following additional R packages were used to compare gaits between groups of cats and limbs with and without MSD.; “sp version 1.4.7” [56], “Rcpp version 1.0.8.3” [57], “raster version 3.5.15” [58], tidyverse version 1.3.2” [59], “rstatix version 0.7.0” [60] and “epitools version 0.5.10.1” [61]. Between-group comparisons of age, bodyweight, BCS, velocity and symmetry indices were made with Student’s t-test or Wilcoxon’s signed ranks test. The effect of sex on the presence of MSD was also assessed by calculating the odds ratio and expressed with associated 95% confidence intervals (95%-CI).

Spatiotemporal gait and ground reaction force data were analysed with linear mixed-effects models, using R packages ‘lme4 version 1.1.29’ [62] and ‘lmerTest version 3.1.3’ [63]. Velocity, sex, BCS, weight and musculoskeletal health category were included as fixed effects, individual cat was included as a random effect and assessed using the population variance (ơ2). Given the many potential fixed effects, bidirectional elimination was performed, with forwards elimination (using a significance of P<0.1) being used to create an initial model for each gait parameter; subsequently, sequential backwards elimination was undertaken where the least significant variable (using a significance of P<0.05) was removed over repeated refinements until the best fit model was found (based on Bayesian information criterion [BIC], where the model with the smallest value BIC was assumed to have the best fit). Residual plots were then assessed to ensure that models model met the assumptions of linearity and homoscedasticity. Results are reported as estimates of the regression coefficients (β) with associated 95%-CI.

Results

Study cohort

Between 2017 and 2020, 211 cats were enrolled in CatPAWS, 53 of which (23 female, 30 male; all neutered) were eligible for inclusion in the current study. The remaining cats did not meet the inclusion criteria of ≥2 successful crossings of the pressure mat or a complete orthopaedic analysis. Descriptive statistics for individual apparently healthy and MSD cats are summarised in Table 2. Raw spatiotemporal and kinetic parameters from all 53 cats are available in S1 Data set.

Table 2. Summary of characteristics and gait parameters from 53 mature cats, expressed as mean (standard deviation) or median and interquartile range.

Apparently Healthy (n = 31) Musculoskeletal disease (n = 22)
Bodyweight (kg) 4.74 (0.942) 5.41 (1.352)
Age (years) 8 7–9 8.1 (1.06)
BCS 5 4.5–6.5 6 6–7.75
Leg length (m) 0.32 0.32–0.34 0.32 0.29–0.33
Velocity (m/sec) 0.69 (0.135) 0.69 (0.161)
Gait cycle time (sec) 0.66 0.62–0.82 0.73 (0.127)
Correction factor 1.02 (0.097) 1.00 (0.100)
Left Forelimb
Stance Time (sec) 0.43 0.39–0.52 0.48 0.39–0.52
Swing Time (sec) 0.25 0.23–0.29 0.26 0.23–0.28
Duty factor (%) 0.64 (0.035) 0.64 (0.023)
Stride Length (m) 0.48 (0.041) 0.48 (0.042)
Stride Velocity (m/sec) 0.70 (0.146) 0.69 (0.162)
Peak Vertical Force (N) 30.14 (8.597) 32.52 (10.257)
Normalised PVF 0.63 (0.072) 0.61 (0.058)
Vertical Impulse (Ns) 10.31 (3.666) 11.05 (4.323)
Normalised VI 0.21 (0.050) 0.21 (0.038)
Right Forelimb
Stance Time (sec) 0.43 0.37–0.52 0.47 0.40–0.54
Swing Time (sec) 0.25 0.23–0.29 0.25 0.23–0.28
Duty factor (%) 0.64 (0.035) 0.65 (0.037)
Stride Length (m) 0.48 (0.044) 0.48 (0.040)
Stride Velocity (m/sec) 0.71 (0.147) 0.70 (0.172)
Peak Vertical Force (N) 29.63 (8.208) 33.01 (11.278)
Normalised PVF 0.62 (0.064) 0.61 (0.075)
Vertical Impulse (Ns) 9.97 (3.537) 11.21 (4.574)
Normalised VI 0.21 (0.043) 0.21 (0.041)
SI Forelimbs Duty Factor (%) 0.35 (1.781) 0.54 (1.462)
SI Forelimbs PVF (%) 0.72 (3.120) 0.43 (2.807)
SI Forelimbs VI (%) 1.55 (3.324) 0.39 (3.386)
Left Hindlimb
Stance Time (sec) 0.44 0.37–0.50 0.46 0.38–0.51
Swing Time (sec) 0.30 0.28–0.34 0.31 0.28–0.32
Duty factor (%) 0.60 (0.024) 0.61 (0.034)
Stride Length (m) 0.50 (0.056) 0.49 (0.047)
Stride Velocity (m/sec) 0.70 (0.158) 0.69 (0.158)
Peak Vertical Force (N) 24.49 (7.427) 26.32 (8.506)
Normalised PVF (%) 0.51 (0.075) 0.49 (0.052)
Vertical Impulse (Ns) 7.80 (3.066) 8.54 (3.686)
Normalised VI (%) 0.16 (0.034) 0.16 (0.031)
Right Hindlimb
Stance Time (sec) 0.44 0.28–0.49 0.46 0.40–0.51
Swing Time (sec) 0.30 0.27–0.36 0.32 0.26–0.32
Duty factor (%) 0.60 (0.026) 0.61 (0.038)
Stride Length (m) 0.49 (0.051) 0.49 (0.050)
Stride Velocity (m/sec) 0.70 (0.148) 0.69 (0.163)
Peak Vertical Force (N) 24.59 (7.843) 26.85 (8.889)
Normalised PVF (%) 0.51 (0.081) 0.50 (0.059)
Vertical Impulse (Ns) 7.67 (2.995) 8.64 (3.750)
Normalised VI (%) 0.16 (0.031) 0.16 (0.034)
SI Hindlimbs Duty Factor (%) 0.38 (2.119) 0.09 (2.626)
SI Hindlimbs PVF (%) 0.04 (3.110) 0.89 (2.597)
SI Hindlimbs VI (%) 0.76 (3.641) 0.53 (2.860)

Leg length data is incomplete and was available for n = 27 apparently healthy cats and n = 18 cats with musculoskeletal disease. BCS = body condition score, PVF = peak vertical force, VI = Vertical impulse, sec = seconds, m = meters, N = Newton’s, Ns = Newton seconds, SI = Symmetry index

Median age of the cats was 8 years (IQR 7–9 years), and mean weight was 4.9 kg (SD 1.17 kg). Thirty-one of the 53 (58%) cats were apparently healthy, whilst orthopaedic examination consistent with MSD were present in the remaining 22 cats (42%) cats. Thirteen (59%) of the 22 cats with MSD had multiple limb involvement (both fore and hindlimb involvement), 7 (32%) had forelimb involvement (2 cats unilateral RF, 2 cats bilateral and 3 cats unilateral LF) and 2 (9%) had bilateral hindlimb involvement. At the level of the individual limb per gait cycle, there were 706 ‘healthy’ forelimbs and 254 with MSD available for assessment; there were also 686 ‘healthy’ hindlimbs and 274 with MSD for assessment. In the apparently-healthy group, 15 (48%) and 16 (52%) and of the cats were male and female, respectively; in the MSD group, 15 (68%) and 7 (32%) of the cats were male and female, respectively. The odds of a male cat having MSD was 1.5 (95% CI 0.7–3.1; P = 0.360).

There were no significant differences in age at time of gait analysis (P = 0.940), velocity (P = 0.992), cycle time (P = 0.754) or correction factor (P = 0.486) between apparently healthy and MSD groups. However, bodyweight (P = 0.048) and BCS (P = 0.015) were greater in cats with MSD (5.4kg [1.35]; BCS 6 [IQR 6–7.75]) compared with apparently-healthy cats (4.7 kg [0.94]; BCS 5 [IQR 4.5–6.5]). Male cats (5.5kg [1.13]) were heavier than female cats (4.4kg [0.91]; P<0.001) but there was no between-sex difference in BCS (male cats 6 [IQR 5–7]; female cats 6 [IQR 5–7], P = 0.521), or velocity (male 0.71m/s [0.162]; female 0.66m/s [0.117]; P = 0.220). Leg length measurements were available from 45/53 (85%) cats. There was no significant difference in leg lengths between the groups (P = 0.125).

PVF and VI distribution

Across the cohort, the expected pattern of greater forelimb PVF (cf., hindlimb) was seen in 31/53 cats (58%), with no left-right asymmetry, whilst a similar pattern was seen in VI measures in 34/53 cats (64%) [23]. All individual cat results for PVF and VI distribution are included in the supporting information (S1 File). There was no significant between-group difference in the distribution of PVF (P = 0.096) or VI (P = 1.000). Fig 2 illustrates the typical ground reaction force pattern in one apparently healthy cat with greater PVF and VI in the forelimbs compared with hindlimbs, but no left-right asymmetry.

Fig 2. Box-plot illustrating analysis of variance (ANOVA) of peak vertical force (PVF) and vertical impulse (VI) for individual Cat077.

Fig 2

A) Box-plot illustrating analysis of variance (ANOVA) of peak vertical force (PVF) by limb for individual Cat077 from 29 paw prints collected over 10 crossings. Forelimb PVF was greater than the -hindlimbs PVF, but there was no left-right asymmetry. B) Box-plot illustrating ANOVA of vertical impulse (VI) by limb for individual Cat077 from 29 prints collected over 10 crossings; again, forelimb VI was greater than hindlimb VI but there was no left-right asymmetry.

Pressure data

The number of p-images available varied amongst cats, with a median per limb of 8 (IQR 6–11); however, there were two apparently-healthy cats outliers, with 28 and 29 prints per limb, respectively. A representative example of an apparently-healthy cat forelimb and hindlimb pressure distribution is shown in Fig 3, whilst mean p-images for all cats are included in the supporting information (S1 File). Twelve of 31 cats (39%) and 5/22 cats (23%) in the apparently-healthy and MSD groups, respectively, showed asymmetry between the left and right on either their fore or hindlimbs, but no significant group differences in the presence of intra-cat pressure asymmetry were evident (P = 0.353). Asymmetry was mainly detected in at the peripheral edges of the paw in both groups (10/12 apparently healthy; 4/5 MSD) and restricted to small numbers of pixels (1–3 out of a potential 36); a representative example is shown in Fig 4. Fewer p-images were available (12 [812] vs. 19 [13.5–24.5], P<0.001) from cats where asymmetry was identified, compared with those without asymmetry. Individual cat topological student’s t-test results are included in the supporting information (S1 File).

Fig 3.

Fig 3

An illustrative example of mean palmar (A) and plantar (B) pressure distribution and of topological t-tests in palmar (C) and plantar (D) pressure distribution in the paws from Cat077. Mean images were created from 29 prints per limb and are orientated to the cranial aspect of the paw print to the right side, and the medial aspect to the top of the image. In the difference maps (C&D), red-yellow pixels indicate greater pressures in the left compared with right paws, whilst blue pixels indicate greater pressures in the right compared with left paws, black areas indicate no significant difference. Both palmar (A) and plantar (B) surfaces have two high-pressure areas in both the cranial and caudal sections of the paw surface. There were no statistically significant differences in paw pressure distribution between both the left and right forelimbs (C) and hindlimbs (D) as indicated by the predominately black colouring on the difference map.

Fig 4.

Fig 4

An illustrative example of mean palmar (A) and plantar (B) pressure distribution and of topological t-tests in palmar (C) and plantar (D) pressure distribution in the paw from Cat023. Images were created from 4 prints per limb and are orientated to the cranial aspect of the paw print to the right side, and the medial aspect to the top of the image. In the difference maps, red-yellow pixels indicate greater pressures in the left compared with right paws, whilst blue pixels indicate greater pressures in the right compared with left paws, black areas indicate no significant difference. Both palmar (A) and plantar (B) surfaces have two high-pressure areas in both the cranial and caudal sections of the paw surface. (C) In the palmar surface, there is a significant difference in the paw pressure distribution between the left and right forelimb. In the cranio-medial area the light blue pixel indicates the right forelimb has significantly higher pressure (P = 0.022) than the left forelimb in this area. D) In the plantar surface there is a significant difference in the paw pressure distribution between the left and right hindlimb. On the medial surface of the paw the left hindlimb had significantly higher pressure then the right hindlimb as indicated by the yellow pixel (P = 0.003) on the difference map and in the more central part of the plantar surface the right hindlimb has significantly higher pressure (P = 0.011) than the left hindlimb in this area as indicated by the lighter blue pixel.

Comparing gait parameters in apparently-healthy middle-aged cats and those with MSD

No significant group differences were evident in symmetry indices for either fore- or hindlimbs (Table 3). The MSD group was categorised in two ways for analysis. Firstly, by cat, multi-limb (n = 13), RF (n = 2), LF (n = 3), bilateral fore (n = 2) and bilateral hind (n = 2). As these groupings contained small numbers of cats, those with affected forelimbs were also grouped together (n = 7) and the analysis repeated. An additional analysis, examining individual limbs, was also performed. To recognise the compensatory nature on gait that disease in one limb may have on the remaining limbs, all ‘healthy’ limbs from MSD classified cats were removed from the data set, leaving 580 healthy fore- and hindlimbs left in the comparison to 254 forelimbs and 274 hindlimbs with MSD.

Table 3. Comparison of gait symmetry indices between 31 apparently-healthy cats and 22 cats with musculoskeletal disease.

Forelimbs Hindlimbs
Apparently healthy MSD P value Apparently healthy MSD P value
Duty factor 0.35 (1.781) -0.54 (1.462) 0.961 0.38 (2.119) 0.09 (2.626) 0.167
Peak vertical force 0.72 (3.120) -0.43 (2.807) 0.590 -0.04 (3.110) -0.89 (2.570) 0.475
Peak Impulse 1.55 (3.324) -0.39 (3.386) 0.910 0.76 (3.641) -0.53 (2.860) 0.424

Symmetry indices are expressed in mean and standard deviation, a value of 0.00 indicates perfect symmetry. For the statistical analysis, symmetry indices were all converted to positive numbers. MSD = Musculoskeletal disease.

Regardless of categorisation (individual limb or apparently healthy vs MSD), the presence of MSD had no significant effect on any gait parameters once body weight was included in the model and were not included as fixed effects in any of the final linear mixed-effects models following backwards elimination using BIC (Table 4). Further, there was no significant effect of BCS or sex on any of the gait parameters and so neither of these variables were included in the final models. However, as expected, increasing velocity was associated with swing and stance time and increased stride length across all limbs (P<0.001 for all).

Table 4. Results from final linear mixed-effects models on spatiotemporal and kinetic gait parameters from 53 cats.

Left Forelimb Right Forelimb Left Hindlimb Right Hindlimb
β CI (95%) P β CI P β CI P β CI P
Swing time
(Intercept) 0.367 (0.348,0.386) <0.001 0.363 (0.343,0.383) <0.001 0.400 (0.371,0.430) <0.001 0.399 (0.369,0.430) <0.001
Velocity -0.150 (-0.180,-0.124) <0.001 -0.144 (-0.171,-0.118) <0.001 -0.130 (-0.170,-0.092) <0.001 -0.124 (-0.164,-0.085) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 0.000 0.019 0.001 0.027 0.001 0.039 0.001 0.044
Residual 0.000 0.025 0.001 0.024 0.001 0.036 0.001 0.036
Observations 198 198 198 198
Stance time
(Intercept) 0.791 0.750–0.834 <0.001 0.786 0.749–0.822 <0.001 0.685 0.635–0.736 <0.001 0.685 0.638–0.733 <0.001
Velocity -0.466 (-0.522, -0.410) <0.001 -0.464 (-0.513,-0.416) <0.001 -0.330 (-0.399,-0.263) <0.001 -0.334 (-0.393,-0.270) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 0.002 0.048 0.002 0.046 0.003 0.054 0.002 0.049
Residual 0.003 0.054 0.002 0.046 0.004 0.067 0.004 0.064
Observations 198 198 198 198
Stride Length
(Intercept) 0.392 (0.373,0.412) <0.001 0.396 (0.377,0.416) <0.001 0.419 (0.397,0.440) <0.001 0.414 (0.393,0.435) <0.001
Velocity 0.124 (0.099,0.145) <0.001 0.118 (0.094,0.142) <0.001 0.106 (0.081,0.132) <0.001 0.112 (0.088,0.137) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 0.001 0.033 0.001 0.035 0.002 0.045 0.002 0.042
Residual 0.001 0.023 0.000 0.022 0.000 0.022 0.000 0.021
Observations 198 198 198 198
Duty factor
(Intercept) 0.677 (0.653,0.701) <0.001 0.668 (0.638,0.699) <0.001 0.545 (0.511,0.580) <0.001 0.623 (0.598,0.647) <0.001
Velocity -0.053 (-0.086,-0.021) <0.001 -0.040 (-0.081,-0.001) 0.059 -0.004 (-0.029,0.030) 0.981 -0.027 (-0.060,0.006) 0.114
Weight 0.012 0.007–0.018 <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 0.000 0.020 0.001 0.026 0.000 0.013 0.000 0.022
Residual 0.001 0.036 0.002 0.044 0.001 0.035 0.001 0.036
Observations 198 198 198 198
PVF
(Intercept) -4.397 (-8.028,0.762 0.021 -6.123 (-9.151,-2.485) 0.028 -6.227 (-9.721,-2.729) 0.001 -7.162 (-10.816,-3.50) <0.000
Velocity 9.095 (7.121,11.072) <0.001 11.460 (9.623,13.323) <0.001 10.268 (8.423,12.121) <0.001 11.381 (9.591,13.194) <0.001
Weight 5.670 (5.010,6.330) <0.001 5.673 (5.008,6.340) <0.001 4.762 (4.125,5.399) <0.001 4.839 (4.166,5.512) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2e SD
ID (intercept) 7.031 2.652 7.332 2.708 6.630 2.575 7.550 2.748
Residual 7.872 2.806 6.673 2.583 6.800 2.608 6.306 2.511
Observations 480 480 480 480
PVF.NM
(Intercept) 0.481 (0.448, 0.514) <0.001 0.448 (0.418,0.478) <0.001 0.339 (0.308,0.370) <0.001 0.338 (0.307,0.369) <0.001
Velocity 0.198 (0.153, 0.240) <0.001 0.243 (0.204,0.282) <0.001 0.238 (0.199,0.277) <0.001 0.245 (0.207,0.284) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 0.003 0.056 0.002 0.051 0.003 0.054 0.003 0.057
Residual 0.004 0.059 0.003 0.055 0.003 0.055 0.003 0.054
Observations 480 480 480 480
VI Fixed effects; velocity and weight; random effects = cat
(Intercept) 5.570 (3.685,7.450) <0.001 4.400 (2.510,6.285) <0.001 2.113 (0.570,3.648) 0.009 1.845 (0.297,3.383) 0.023
Velocity -9.879 (-10.925,-8.851) <0.001 -8.954 (-9.864,-8.054) <0.001 -6.634 (-7.628,-5.667) <0.001 -6.023 (-6.891,-5.181) <0.001
Weight 2.307 (1.965,2.648) <0.001 2.390 (2.041,2.738) <0.001 2.058 (1.785,2.330) <0.001 2.019 (1.740,2.298) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 1.875 1.369 2.037 1.427 1.111 1.054 1.258 1.122
Residual 2.159 1.469 1.580 1.257 2.023 1.422 1.439 1.199
Observations 480 480 480 480
VI.NM
(Intercept) 0.348 0.332–0.363 <0.001 0.334 0.319–0.348 <0.001 0.247 0.233–0.261 <0.001 0.242 0.229–0.255 <0.001
Velocity -0.201 (-0.220,0.182) <0.001 -0.185 (-0.202,0.168) <0.001 -0.130 (-0.148,0.112) <0.001 -0.124 (-0.140,0.107) <0.001
Random ơ2 SD ơ2 SD ơ2 SD ơ2 SD
ID (intercept) 0.001 0.030 0.001 0.029 0.000 0.022 0.001 0.022
Residual 0.001 0.026 0.001 0.024 0.001 0.026 0.001 0.023
Observations 480 480 480 480

Final results following backwards elimination using BIC to, individual cat included as a random effect. Observations refer to the total number of gait cycles (198) or ground reaction forces (480). PVF = Peak Vertical Force, PVF.NM = Peak Vertical Force normalised to bodyweight, VI = Vertical impulse, VI.NM = Vertical impulse normalised to bodyweight, β = regression coefficients, ơ2 = population variance, SD = standard deviation, ID = individual cat. Significant P-values are presented in bold.

Duty factor was significantly negatively associated with increasing velocity in the LF limb (β -0.053, 95%CI -0.086, -0.012; P<0.001) but not in the RF (β -0.040, 95%CI -0.081, -0.001; P = 0.059), LH (β -0.004, 95%CI -0.029, 0.030; P = 0.98) or RH (β -0.027, 95%CI -0.060, 0.006; P = 0.114). Inclusion of bodyweight significantly improved the fit of the final model for the duty factor outcome variable in the left hindlimb (β 0.012, 95%CI 0.007, 0.018; P<0.001). However, there was no significant effect of bodyweight on duty factor for any other limb and it was not included in any of these final models. The population variance (ơ2) for swing time, stance time, stride length and duty factor were all small (<0.01) indicating little variation amongst the different measurements.

Peak vertical force (PVF) was associated with greater velocity and bodyweight (both P<0.001), the association to bodyweight was lost when PVF was normalised. Population variance (ơ2) was large in all limbs (ranging from 6.63–7.55). Furthermore, VI was negatively associated with greater velocity (P<0.001) and positively associated with greater bodyweight (P<0.001), whilst ơ2 was moderate (range 2.01–2.39 in all limbs). As with PVF, the significant association with bodyweight was lost when VI was normalised. Population variance (ơ2) was low (<0.01) when both PVF and VI were normalised to bodyweight.

Variation in gait parameters within apparently-healthy middle-aged cats and within those with MSD

The CV was assessed for all gait parameters and is presented in the supporting information (S1 and S2 Tables). For both groups (apparently healthy and MSD cats), there was large variation (>3.0%) in all parameters. The least variation was seen with stride length (CV range 3.7–4.9% across both groups) and force normalised to bodyweight (range across both groups 9.9–11.8%).

Discussion

The aim of the current study was to determine if cats with and without MSD would differ in paw pressure and spatiotemporal and kinetic gait metrics. This study has determined that these parameters could not differentiate cats suffering from MSD from cats that were apparently healthy. These findings are most likely to be the result of the large intra- and inter-cat variation seen (S1 and S2 Tables), and also variability in how MSD presented, not least the fact that multi-limb disease was common. Given the small number of cats assessed, especially those with unilateral disease, the lack of significant differences is not surprising. Where significant differences between healthy and MSD cats have previously been identified using gait analysis, the groups studied either a specific disease condition (e.g., coxofemoral joint arthritis [28]) or unilateral disease (e.g. stifle disease or post-surgical intervention [26, 27, 29, 30]). Intra-cat gait variability in this study, as measured by CV, was greater than previously reported [24], both in apparently-healthy and MSD groups. These findings suggest that this type of gait analysis may have limited utility in pet cats with naturally-occurring non-specific MSD. Longitudinal gait analysis, tracking changes in individuals, might prove to be a better approach for cats. Additionally, further work examining the range of motion of joints and limb placement would improve understanding of the impact of MSD in cats. In this regard, DJD is already known to be associated with a reduced range of motion as assessed by goniometry in cats [35]. Use of markers and video analysis of gait was considered during the conception of this study but was not included due to practicalities associated with cat compliance, the suitability of the laboratory space available for free roaming cats to be in and the wider data collection required for the CatPAWs conception [38].

Differences between the current study and previous research might also be the result of different methodology. In an earlier study [24], each cat undertook three trials using a longer walkway, enabling more gait cycles to be collected. Further, screening radiography was performed (including controls) as part of their orthopaedic examination [24]; the lack of screening radiography in the current study might have led to cats incorrectly being assigned to the apparently-healthy group.

This study confirms the need to control for the velocity of the cats whilst collecting gait parameters, indicating that pressure sensitive treadmills might be beneficial in circumstances where cross-sectional analysis across a population of cats is required. However, variation in velocity may be a useful parameter to assess with naturally occurring disease. Differences in speed between healthy and mobility-impaired dogs have been demonstrated [64], where dogs with mobility impairment had a naturally lower velocity, suggesting that velocity might be a useful variable for diagnosis in this species. Velocity did not differ significantly between groups in the current study, and it is difficult to explain why cats and dogs with limb mobility issues appear to be different in this respect. In previous research, dogs were led by their owners at a trot [64], whereas the cats in the current study could choose their own speed. It might be worthwhile assessing longitudinal changes in velocity in relation to the development of MSD, either via gait analysis or accelerometer data. (67) Ideally, speed (and other spatiotemporal parameters) should also be normalised to leg length [65]; however, this was not possible in the current study because this measurement was not taken in all cats. However, where this was recorded, no significant between-group difference was evident (P = 0.125, Table 2), suggesting that differences in leg length were unlikely to have unduly influenced the speed and other spatiotemporal parameters.

Unlike dogs, cats use more three-dimensional space in their daily lives (e.g. through climbing) and changes in jumping behaviours have remained important within DJD clinical metrology instrument refinement [66, 67]. With this in mind, accelerometers are potentially a better tool to explore changes in activity with naturally occurring musculoskeletal disease in cats, however there is significant variation seen between cats [68] and to date their use has best been established with intervention type studies where the cat acts as their own control [33, 69]. Additionally, gait speed has been associated with ageing and cognitive performance in dogs [70], so exploring cognitive decline as a comorbidity with musculoskeletal disease in ageing cats should be considered when investigating changes in mobility and velocity in ageing cats.

In addition to the marked intra- and inter-cat variability in gait data, other study limitations include the small sample size, the resolution of the pressure mat used and limited number of gait cycles recorded for each cat. It has been suggested that a minimum of 400 steps is required to capture kinematic variability in humans walking on treadmills [71], although more recent work has suggested that there are only minor advantages to having >200 steps per subject in analyses of peak plantar pressure in humans [44]. Conversely, sample sizes of <20 might not accurately reflect the population mean and might be insufficient for assessing pixel-level variation using topological approaches such as pSPM [44]. The number of steps, per cat per limb, in this study varied from 4 to 29, which might have contributed to the degree of asymmetry detected using topological t-testing in both groups, as supported by the observed relationship between number of p-images and the presence of asymmetry. Furthermore, the greatest asymmetry was identified around the periphery of the paw, and this might simply reflect minor changes in overall contact area step-to-step, as well as minor inconsistencies in the p-image registration process.

Available sample size was also limited by the willingness of cats to walk across the pressure sensitive walkway, not least the cats with MSD. Furthermore, cats in the MSD group were significantly heavier than those in the apparently healthy group, which might partly be due to the greater proportion of male cats represented. Body condition score was also greater, suggesting a possible effect of increased adiposity, consistent obesity being a risk factor for MSD in cats [72]. As well as an increased mechanical load, the metabolic effects of obesity may create a pro-inflammatory state-and further exacerbate the clinical signs [73]. However, given that overweight adult cats are also less active [74], our results might have been influenced by selection bias, because orthopaedic examination was used as the only screening method for feline MSD. Conversely, food was used as a reward, to encourage cats to cross the walkway, which might instead have selected for food motivated cats. Nonetheless, sex and BCS were not retained in any of the final models and bodyweight was not retained after normalisation. Therefore, increased bodyweight and BCS did not cause any detectable differences in the gait parameters assessed.

Conclusions

In this study, cats with MSD had significantly greater bodyweight and BCS than apparently-healthy cats, but there were no significant differences in paw pressure and spatiotemporal or kinetic gait metrics. These results are likely to be the result of both high intra- and inter-cat variability, difficulties in collecting usable gait data from pet cats and the multi-limb nature of MSD in cats. Future work should examine gait in a larger population of cats with defined musculoskeletal disorders (e.g. hip dysplasia or osteoarthritis), and aim to capture more images per cat, either by increasing the number of pressure mat crossings or by using a longer pressure mat. Use of a walkway with greater resolution is also recommended for pSPM analysis. Finally, to determine age-related changes in gait, cats should be monitored longitudinally during their senior years.

Supporting information

S1 Table. Summary of co-efficient of variation in gait parameters from n = 31 apparently healthy middle-aged cats.

Min = minimum value, Max = maximum value, Q1 = 1st quartile, Q3 = 3rd quartile, SD = standard deviation. Values in bold indicate distribution.

(DOCX)

pone.0314629.s001.docx (21.8KB, docx)
S2 Table. Summary of co-efficient of variation in gait parameter from n = 22 middle-aged cats with musculoskeletal disease.

Min = minimum value, Max = maximum value, Q1 = 1st quartile, Q3 = 3rd quartile, SD = standard deviation. Values in bold indicate distribution.

(DOCX)

pone.0314629.s002.docx (21.9KB, docx)
S1 File. Analysis of variance (ANOVA) of peak vertical force (PVF) and vertical impulse (VI) by limb and mean palmar and plantar pressure distribution and topological t-tests for palmar and plantar pressure distribution in the paws, of 53 cats.

(DOCX)

pone.0314629.s003.docx (14.1MB, docx)
S1 Data set. Raw spatiotemporal and kinetic parameters from 53 cats.

Group = Musculoskeletal disease (MSD) or Apparently Healthy (AH), Walk = gait cycle recorded, W(N) = cats weight in newtons at time of recording, LF, RF., LH, RH indicated limb recorded. MaximunForceBW = maximum force as a % of body weight, MaximunForceN = maximum force in newtons, FTIBW = maximum vertical impulse as a % of body weight, FTIM = maximum vertical impulse in newtons, MPP = maximum peak pressure in newtons per m2, TTFI = maximum vertical impulse for all four limbs, other parameters are as outlined in Table 1 of the main manuscript.

(XLSX)

pone.0314629.s004.xlsx (149.8KB, xlsx)

Acknowledgments

Kelly Eyre RVN for her involvement in the investigation and assisting with gait data collection, Rebecca Fonseka for her assistance in reviewing and sorting the raw gait data, the staff at the University of Liverpool Veterinary Practice for allowing us to work in their premises and all the owners of the cats for attending the clinic.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The study was funded by a grant from Royal Canin. The sponsor collaborated on the design of the study and reviewed the manuscript for quality purposes prior to submission. However, they were not involved in data collection, clinical assessments, data analysis, interpretation, manuscript writing or the decision to submit the work for publication.

References

  • 1.Lascelles BDX. Feline Degenerative Joint Disease. Veterinary Surgery. 2010;39: 2–13. doi: 10.1111/j.1532-950X.2009.00597.x [DOI] [PubMed] [Google Scholar]
  • 2.Dowgray N, Comerford E. Feline musculoskeletal ageing How are we diagnosing and treating musculoskeletal impairment? J Feline Med Surg. 2020;22: 1069–1083. doi: 10.1177/1098612X20965832 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Godfrey DR. Osteoarthritis in cats: A retrospective radiological study. Journal of Small Animal Practice. 2005;46: 425–429. doi: 10.1111/j.1748-5827.2005.tb00340.x [DOI] [PubMed] [Google Scholar]
  • 4.Clarke SP, Mellor D, Clements DN, Gemmill T, Farrell M, Carmichael S, et al. Prevalence of radiographic signs of degenerative joint disease in a hospital population of cats. Veterinary Record. 2005;157: 793–799. doi: 10.1136/vr.157.25.793 [DOI] [PubMed] [Google Scholar]
  • 5.Hardie EM, Roe SC, Martin FR. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994–1997). J Am Vet Med Assoc. 2002;220: 628–632. doi: 10.2460/javma.2002.220.628 [DOI] [PubMed] [Google Scholar]
  • 6.Lascelles BDX, Henry JB, Brown J, Robertson I, Sumrell A, Simpson W, et al. Cross-Sectional Study of the Prevalence of Radiographic Degenerative Joint Disease in Domesticated Cats. Veterinary Surgery. 2010;39: 535–544. doi: 10.1111/j.1532-950X.2010.00708.x [DOI] [PubMed] [Google Scholar]
  • 7.Slingerland LI, Hazewinkel HAW, Meij BP, Picavet P, Voorhout G. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats. Veterinary Journal. 2011;187: 304–309. doi: 10.1016/j.tvjl.2009.12.014 [DOI] [PubMed] [Google Scholar]
  • 8.O’Neill DG, Church DB, McGreevy PD, Thomson PC, Brodbelt DC. Prevalence of disorders recorded in cats attending primary-care veterinary practices in England. Veterinary Journal. 2014;202: 286–291. doi: 10.1016/j.tvjl.2014.08.004 [DOI] [PubMed] [Google Scholar]
  • 9.Bennett D, Ariffin SMZ, Johnston P. Osteoarthritis in the cat: 1. How common is it and how easy to recognise? J Feline Med Surg. 2012;14: 65–75. doi: 10.1177/1098612X11432828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bennett D, Morton C. A study of owner observed behavioural and lifestyle changes in cats with musculoskeletal disease before and after analgesic therapy. J Feline Med Surg. 2009;11: 997–1004. doi: 10.1016/j.jfms.2009.09.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Klinck MP, Frank D, Guillot M, Troncy E. Owner-perceived signs and veterinary diagnosis in 50 cases of Feline osteoarthritis. Canadian Veterinary Journal. 2012;53: 1181–1186. [PMC free article] [PubMed] [Google Scholar]
  • 12.Benito J, Hansen B, Depuy V, Davidson GS, Thomson A, Simpson W, et al. Feline musculoskeletal pain index: Responsiveness and testing of criterion validity. J Vet Intern Med. 2013;27: 474–482. doi: 10.1111/jvim.12077 [DOI] [PubMed] [Google Scholar]
  • 13.Klinck MP, Monteiro BP, Lussier B, Guillot M, Moreau M, Otis C, et al. Refinement of the Montreal Instrument for Cat Arthritis Testing, for Use by Veterinarians: detection of naturally occurring osteoarthritis in laboratory cats. J Feline Med Surg. 2017;20: 728–740. doi: 10.1177/1098612X17730172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zamprogno H, Hansen BD, Bondell HD, Sumrell AT, Simpson W, Robertson ID, et al. Item generation and design testing of a questionnaire to assess degenerative joint disease-associated pain in cats. Am J Vet Res. 2010;71: 1417–1424. doi: 10.2460/ajvr.71.12.1417 [DOI] [PubMed] [Google Scholar]
  • 15.Benito J, DePuy V, Hardie E, Zamprogno H, Thomson A, Simpson W, et al. Reliability and discriminatory testing of a client-based metrology instrument, feline musculoskeletal pain index (FMPI) for the evaluation of degenerative joint disease-associated pain in cats. Veterinary Journal. 2013;196: 368–373. doi: 10.1016/j.tvjl.2012.12.015 [DOI] [PubMed] [Google Scholar]
  • 16.Gruen ME, Dorman DC, Lascelles BDX. Caregiver placebo effect in analgesic clinical trials for cats with naturally occurring degenerative joint disease-associated pain. Veterinary Record. 2017;180: 473. doi: 10.1136/vr.104168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sheldon JD, Adkesson MJ, Allender MC, Bailey RS, Langan JN, Chinnadurai SK. Evaluation of a pressure sensitive walkway for objective gait analysis in normal and arthritic domestic ducks (Cairina moschata domestica). PLoS One. 2019;14: 1–13. doi: 10.1371/journal.pone.0220468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sheldon JD, Adkesson MJ, Allender MC, Balko JA, Bailey RS, Langan JN, et al. Objective gait analysis in humboldt penguins (spheniscus humboldti) using a pressure-sensitive walkway. Journal of Zoo and Wildlife Medicine. 2020;50: 910–916. doi: 10.1638/2019-0054 [DOI] [PubMed] [Google Scholar]
  • 19.Bockstahler BA, Vobornik A, Müller M, Peham C. Compensatory load redistribution in naturally occurring osteoarthritis of the elbow joint and induced weight-bearing lameness of the forelimbs compared with clinically sound dogs. Veterinary Journal. 2009;180: 202–212. doi: 10.1016/j.tvjl.2007.12.025 [DOI] [PubMed] [Google Scholar]
  • 20.Lascelles BDX, Findley K, Correa M, Marcellin-Little D, Roe S. Kinetic evaluation of normal walking and jumping in cats, using a pressure-sensitive walkway. Vet Rec. 2007;160: 512–516. doi: 10.1136/vr.160.15.512 [DOI] [PubMed] [Google Scholar]
  • 21.LeQuang T, Maitre P, Colin A, Viguier E. Spatial, temporal and kinetic evaluation of normal cats at walk, using a pressure walkway. Comput Methods Biomech Biomed Engin. 2008;11: 137–138. doi: 10.1080/10255840802296855 [DOI] [Google Scholar]
  • 22.Verdugo MR, Rahal SC, Agostinho FS, Govoni VM, Mamprim MJ, Monteiro FOB. Kinetic and temporospatial parameters in male and female cats walking over a pressure sensing walkway. BMC Vet Res. 2013;9: 129. Artn 129\r doi: 10.1186/1746-6148-9-129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Stadig SM, Bergh AK. Gait and jump analysis in healthy cats using a pressure mat system. J Feline Med Surg. 2015;17: 523–9. doi: 10.1177/1098612X14551588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Schnabl-feichter E, Tichy A, Bockstahler B. Coefficients of variation of ground reaction force measurement in cats. PLoS One. 2017;12: 1–12. doi: 10.1371/journal.pone.0171946 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Schnabl-Feichter E, Tichy A, Gumpenberger M, Bockstahler B. Comparison of ground reaction force measurements in a population of Domestic Shorthair and Maine Coon cats. PLoS One. 2018;13: e0208085. doi: 10.1371/journal.pone.0208085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Stadig S, Lascelles BDX, Bergh A. Do cats with a cranial cruciate ligament injury and osteoarthritis demonstrate a different gait pattern and behaviour compared to sound cats? Acta Vet Scand. 2016;58: 70. doi: 10.1186/s13028-016-0248-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Romans CW, Conzemius MG, Horstman CL, Gordon WJ, Evans RB. Use of Pressure Gait analysis in cats with and without bilaterla onychectomy. Am J Vet Res. 2004;65: 1276–1278. [DOI] [PubMed] [Google Scholar]
  • 28.Guillot M, Moreau M, D’Anjou MA, Martel-Pelletier J, Pelletier JP, Troncy E. Evaluation of Osteoarthritis in Cats: Novel Information from a Pilot Study. Veterinary Surgery. 2012;41: 328–335. doi: 10.1111/j.1532-950X.2012.00976.x [DOI] [PubMed] [Google Scholar]
  • 29.Schnabl-Feichter E, Tichy A, Bockstahler B. Evaluation of a pressure plate for detection of hind limb lameness in cats. PLoS One. 2020;15: e0231904. doi: 10.1371/journal.pone.0231904 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Schnabl-Feichter E, Schnabl S, Tichy A, Gumpenberger M, Bockstahler B. Measurement of ground reaction forces in cats 1 year after femoral head and neck ostectomy. J Feline Med Surg. 2021;23: 302–309. doi: 10.1177/1098612X20948143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Robinson D a, Romans CW, Gordon-evans WJ, Evans RB, Conzemius MG. Evaluation of short-term limb function following unilateral carbon dioxide laser or Scalpel Onychectomy in Cats. Journal of the American Veterinary Medical Association (JAVMA). 2007;230: 353–358. doi: 10.2460/javma.230.3.353 [DOI] [PubMed] [Google Scholar]
  • 32.Romans CW, Gordon WJ, Robinson D a, Evans R, Conzemius MG. Effect of postoperative analgesic protocol on limb function following onychectomy in cats. J Am Vet Med Assoc. 2005;227: 89–93. doi: 10.2460/javma.2005.227.89 [DOI] [PubMed] [Google Scholar]
  • 33.Guillot M, Moreau M, Heit M, Martel-Pelletier J, Pelletier JP, Troncy E. Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools. Veterinary Journal. 2013;196: 360–367. doi: 10.1016/j.tvjl.2013.01.009 [DOI] [PubMed] [Google Scholar]
  • 34.Dowgray N, Pinchbeck G, Eyre K, Biourge V, Comerford E, German AJ. Aging in Cats: Owner Observations and Clinical Finding in 206 Mature Cats at Enrolment to the Cat Prospective Aging and Welfare Study. Front Vet Sci. 2022;9: 1–13. doi: 10.3389/fvets.2022.859041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lascelles BDX, Dong Y-H, Marcellin-Little DJ, Thomson A, Wheeler S, Correa M. Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in cats. BMC Vet Res. 2012;8: 10. doi: 10.1186/1746-6148-8-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kerwin S. Orthopedic examination in the cat: Clinical tips for ruling in/out common musculoskeletal disease. J Feline Med Surg. 2012;14: 6–12. doi: 10.1177/1098612X11432822 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Scott EM, Davies V, Nolan AM, Noble CE, Dowgray NJ, German AJ, et al. Validity and Responsiveness of the Generic Health-Related Quality of Life Instrument (VetMetricaTM) in Cats With Osteoarthritis. Comparison of Vet and Owner Impressions of Quality of Life Impact. Front Vet Sci. 2021;8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Dowgray NJ. An Epidemiological, Clinical and biomechanical study in to age-related changes in 206 middle-aged cats; the CATPAW Study. 2021. doi: 10.17638/03124250 [DOI] [Google Scholar]
  • 39.Agostinho FS, Rahal SC, Araújo FAP, Conceição RT, Hussni CA, El-Warrak AO, et al. Gait analysis in clinically healthy sheep from three different age groups using a pressure-sensitive walkway. BMC Vet Res. 2012;8: 10–14. doi: 10.1186/1746-6148-8-87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pataky TC, Goulermas JY. Pedobarographic statistical parametric mapping (pSPM): A pixel-level approach to foot pressure image analysis. J Biomech. 2008;41: 2136–2143. doi: 10.1016/j.jbiomech.2008.04.034 [DOI] [PubMed] [Google Scholar]
  • 41.Pataky TC, Caravaggi P, Savage R, Parker D, Goulermas JY, Sellers WI, et al. New insights into the plantar pressure correlates of walking speed using pedobarographic statistical parametric mapping (pSPM). J Biomech. 2008;41: 1987–1994. doi: 10.1016/j.jbiomech.2008.03.034 [DOI] [PubMed] [Google Scholar]
  • 42.McClymont J, Pataky TC, Crompton RH, Savage R, Bates KT. The nature of functional variability in plantar pressure during a range of controlled walking speeds. R Soc open sci. 2016;3. doi: 10.1098/rsos.160369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Pataky TC, Goulermas JY, Crompton RH. A comparison of seven methods of within-subjects rigid-body pedobarographic image registration. J Biomech. 2008;41: 3085–3089. doi: 10.1016/j.jbiomech.2008.08.001 [DOI] [PubMed] [Google Scholar]
  • 44.McClymont J, Savage R, Pataky TC, Crompton R, Charles J, Bates KT. Intra-subject sample size effects in plantar pressure analyses. PeerJ. 2021; 1–22. doi: 10.7717/peerj.11660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Charles JP, Grant B, D’Août K, Bates KT. Foot anatomy, walking energetics, and the evolution of human bipedalism. J Hum Evol. 2021;156: 103014. doi: 10.1016/j.jhevol.2021.103014 [DOI] [PubMed] [Google Scholar]
  • 46.Bates KT, Collins D, Savage R, McClymont J, Webster E, Pataky TC, et al. The evolution of compliance in the human lateral mid-foot. Proceedings of the Royal Society B: Biological Sciences. 2013;280. doi: 10.1098/rspb.2013.1818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Pataky TC, Savage R, Bates KT, Sellers WI, Crompton RH. Short-term step-to-step correlation in plantar pressure distributions during treadmill walking, and implications for footprint trail analysis. Gait Posture. 2013;38: 1054–1057. doi: 10.1016/j.gaitpost.2013.03.016 [DOI] [PubMed] [Google Scholar]
  • 48.Bates KT, Savage R, Pataky TC, Morse SA, Webster E, Falkingham PL, et al. Does footprint depth correlate with foot motion and pressure? J R Soc Interface. 2013;10. doi: 10.1098/rsif.2013.0009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. Available: https://www.r-project.org/ [Google Scholar]
  • 50.Wickham H. ggplot2: Elegant Graphics for Data Analysis. 2016. [Google Scholar]
  • 51.Kassambara A. ggpubr: “ggplot2” Based Publication Ready Plots. 2019. [Google Scholar]
  • 52.Wickham H. Reshaping data with the reshape package. J Stat Softw. 2007;21. [Google Scholar]
  • 53.Pataky TC. Generalized n-dimensional biomechanical field analysis using statistical parametric mapping. J Biomech. 2010;43: 1976–1982. doi: 10.1016/j.jbiomech.2010.03.008 [DOI] [PubMed] [Google Scholar]
  • 54.Hausdorff J, Purdon P, Pen C, Ladin Z, Wei J, Goldberger A. Fractal dynamics of human gait: stability of long-range correlations in stride interval fluctuations. J Appl Physiol. 1996;8: 1446–1447. doi: 10.1152/jappl.1996.80.5.1448 [DOI] [PubMed] [Google Scholar]
  • 55.Jordan K, Challis JH, Newell KM. Walking speed influences on gait cycle variability. Gait Posture. 2007;26: 128–134. doi: 10.1016/j.gaitpost.2006.08.010 [DOI] [PubMed] [Google Scholar]
  • 56.Bivand RS, Pebesma EJ. Classes and methods for spatial data in R. R News. 2005;5: 9–13. [Google Scholar]
  • 57.Eddelbuettel D, Francois R. Rcpp: Seamless R and C++ Integration. J Stat Softw. 2011;40: 1–18. [Google Scholar]
  • 58.Robert J. Hijmans. Raster: Geographic Data Analysis and Modeling. 2019. [Google Scholar]
  • 59.Wickham H, Averick M, Bryan J, Change W. Welcome to the tidyverse. J Open Source Softw. 2019;4: 1686. [Google Scholar]
  • 60.Kassambara A. rstatix: Pipe-friendly framework for basic statiscal tests. 2020. [Google Scholar]
  • 61.Aragon TJ. Epitools: Epidemiology tools. 2020. [Google Scholar]
  • 62.Bates D, Machlet M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using {lme4}. J Stat Softw. 2015;67: 1–48. [Google Scholar]
  • 63.Kuznetsova A, Brockhoff P, Christensent R. Tests in Linear Mixed Effects Models. J Stat Softw. 2017;82: 1–26. [Google Scholar]
  • 64.Clark NL, Bates KT, Harris LK, Tomlinson AW, Murray JK, Comerford EJ. GenPup-M: A novel validated owner-reported clinical metrology instrument for detecting early mobility changes in dogs. PLoS One. 2023;18: e0291035. doi: 10.1371/journal.pone.0291035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Volstad N, Nemke B, Muir P. Variance associated with the use of relative velocity for force platform gait analysis in a heterogeneous population of clinically normal dogs. Veterinary Journal. 2016;207: 80–84. doi: 10.1016/j.tvjl.2015.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Enomoto M, Lascelles BDX, Robertson JB, Gruen ME. Refinement of the Feline Musculoskeletal Pain Index (FMPI) and development of the short-form FMPI. J Feline Med Surg. 2021. doi: 10.1177/1098612X211011984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Enomoto M, Lascelles BDX, Gruen ME. Development of a checklist for the detection of degenerative joint disease-associated pain in cats. J Feline Med Surg. 2020. doi: 10.1177/1098612X20907424 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Andrews CJ, Potter MA, Thomas DG. Quantification of activity in domestic cats (Felis catus) by accelerometry. Appl Anim Behav Sci. 2015;173: 17–21. doi: 10.1016/j.applanim.2015.05.006 [DOI] [Google Scholar]
  • 69.Gruen ME, Myers JAE, Lascelles BDX. Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study. Front Vet Sci. 2021;8. doi: 10.3389/fvets.2021.610028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Mondino A, Khan M, Case B, Fefer G, Panek WK, Gruen ME, et al. Winning the race with aging: age-related changes in gait speed and its association with cognitive performance in dogs. Front Vet Sci. 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Owings TM, Grabiner MD. Measuring step kinematic variability on an instrumented treadmill: How many steps are enough? J Biomech. 2003;36: 1215–1218. doi: 10.1016/s0021-9290(03)00108-8 [DOI] [PubMed] [Google Scholar]
  • 72.Teng KT, McGreevy PD, Toribio JALML, Raubenheimer D, Kendall K, Dhand NK. Associations of body condition score with health conditions related to overweight and obesity in cats. Journal of Small Animal Practice. 2018;6: 1–13. doi: 10.1111/jsap.12905 [DOI] [PubMed] [Google Scholar]
  • 73.German AJ, Ryan VH, German AC, Wood IS, Trayhurn P. Obesity, its associated disorders and the role of inflammatory adipokines in companion animals. Veterinary Journal. 2010;185: 4–9. doi: 10.1016/j.tvjl.2010.04.004 [DOI] [PubMed] [Google Scholar]
  • 74.de Godoy MRC, Shoveller AK. Overweight adult cats have significantly lower voluntary physical activity than adult lean cats. J Feline Med Surg. 2017;19: 1267–1273. doi: 10.1177/1098612X17694252 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Vanessa Carels

21 Aug 2024

PONE-D-24-25503Paw pressure and gait in middle-aged client-owned cats with and without naturally-occurring musculoskeletal diseasePLOS ONE

Dear Dr. Dowgray,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. 

Please submit your revised manuscript by Oct 04 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Vanessa Carels

Staff Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Competing Interests section: "AJG is an employee of the University of Liverpool, but his post is financially supported by Royal Canin, a division of Mars Petcare. AJG has also received financial remuneration for providing educational material, speaking at conferences, and consultancy work from this company; all such remuneration has been for projects unrelated to the work reported in this manuscript. At the time the study was performed, ND was undertaking a post-graduate studentship funded by Royal Canin. Since October 2020, ND has been employed by International Cat Care, but also holds a part-time post-doctoral research position at the University of Liverpool, funded by Royal Canin."

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: ""This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting study investigating if a pressure sensitive walkway can differentiate cats with MSD and without MSD. Methods are thoroughly written, and limitations are well discussed. I have only several minor comments on the manuscript, and they are below.

1. Table2. If the authors used the following formula to calculate the symmetry indices (from the cited papers), negative values should not be seen. SIXFz=abs((XFzFL-XFzFR)/(XFzFL+XFzFR))x100

2. The reviewer is not clear about the definition of “forelimb involvement”, “hindlimb involvement” and “multiple limb involvement”. Does forelimb involvement mean that only a single forelimb is affected? If bilateral forelimbs are affected, that cat falls into the “multiple limb involvement”?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Dec 18;19(12):e0314629. doi: 10.1371/journal.pone.0314629.r002

Author response to Decision Letter 0


24 Aug 2024

Thank you for your helpful review, we hope are following amendments are satisfactory.

Point 1: Apologies, I had forgotten to apply the absolute value to the formular, this has now been corrected.

Point 2: Thank you for raising this point. I have clarified the groups a little more in the results (see below) and in doing so noticed a mistake in the main manuscript, one of the forelimb cases had been miss counted as being multilimb, this mistake has been corrected. This mistake did not affect the files being used for statistical analysis and will have no impact on the results.

‘Thirteen (59%) of the 22 cats with MSD had multiple limb involvement (both fore and hindlimb involvement), 7 (32%) had forelimb involvement (2 cats unilateral RF, 2 cats bilateral and 3 cats unilateral LF) and 2 (9%) had bilateral hindlimb involvement.’

Attachment

Submitted filename: Response to reviewers.docx

pone.0314629.s005.docx (16.7KB, docx)

Decision Letter 1

Antal Nógrádi

7 Oct 2024

PONE-D-24-25503R1Paw pressure and gait in middle-aged client-owned cats with and without naturally-occurring musculoskeletal diseasePLOS ONE

Dear Dr. Dowgray,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been taken over from the previous Editor in the R1 phase, by when the necessary revision suggested by reviewer 1 has already been completed.  A second reviewer has been invited to review the manuscript version R1 and according to the suggestions I ask you to carry out an in-depth revision.  I realize that this is an unusual review process, but it appears to improve the manuscript considerably. Please, take into consideration the reviewer's suggestions,especially the one which suggests re-grouping the animals and thus possibly yielding significant results. Please submit your revised manuscript by Nov 21 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Antal Nógrádi, M.D., Ph.D., D.Sc.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: This is an interesting paper investigating the possible gait changes in cats with MSD. The experiment is based on the paw pressure and pattern of the animals. The collected data and the statistical tests are appropriate. The authors could not detect significant changes in the aspects of the gait, even with the significant weight differences among the affected and intact animals. It is likely that other aspects of the gait like joint angles and paw lifting abilities would provide more details about the changes of locomotion. The central thoughts of the manuscript are logically established; the authors use English in a most proper way.

There are a few suggestions as follows:

-The authors should consider to redistribute the animals into experimental groups more carefully. Based upon the number and position of the affected limb(s) well-defined groups should be created and each of these groups should be compared to the intact data. This is important because with locomotor diseases compensational processes can strongly distort the collected data depending on the number and sides of the affected limb or limbs. This way the mentioned “intra-cat and intercat” gait variabilities may be avoided, and there would be a chance to detect significant differences in some of the parameters even if “n” of the groups obviously drops this way. Please make clear what groups and subgroups you intend to set up and what plans you intend to make in order to find possible significance between these groups.

-In the Discussion the authors should emphasize more the possible use of other gait measuring methods.

-line 419: Control of the velocity is not necessarily needed if the collected intact data is sorted and characterized by that aspect. By comparing the matching MSD data, different velocities make the assessment even more precise.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Dec 18;19(12):e0314629. doi: 10.1371/journal.pone.0314629.r004

Author response to Decision Letter 1


11 Nov 2024

Dear Editor and Reviewer 2,

Thank you for your time and thoughts in reviewing our paper ‘Paw pressure and gait in middle-aged client-owned cats with and without naturally-occurring musculoskeletal disease’. Your comments and advice are very much appreciated. We have carefully considered all points made and made amendments to the manuscript as a result. These changes, and our responses to your comments, are covered in the point-by-point response that follows:

1. The authors should consider to redistribute the animals into experimental groups more carefully. Based upon the number and position of the affected limb(s) well-defined groups should be created and each of these groups should be compared to the intact data. This is important because with locomotor diseases compensational processes can strongly distort the collected data depending on the number and sides of the affected limb or limbs. This way the mentioned “intra-cat and intercat” gait variabilities may be avoided, and there would be a chance to detect significant differences in some of the parameters even if “n” of the groups obviously drops this way. Please make clear what groups and subgroups you intend to set up and what plans you intend to make in order to find possible significance between these groups.

We have taken into consideration comments about regrouping the cats and further analysis. The sub-setting the cats with musculoskeletal disease into different groups was something we had looked at previously when analyzing the data, but had deliberately excluded as the group sizes tend to be very small. Given the variation in our data (discussed at length in our manuscript), we felt it somewhat redundant to include such small group comparisons. However, as requested, we have now included aspects of this in our resubmission please see, lines 119-120 and 361-373 of our resubmission. The only significance found, at this level between the sub-groups, was that diseased forelimbs had significantly greater forelimb maximum PVF than non-diseased forelimbs; however, this significance disappeared when comparing percentage of total force (to account to some extent for size differences) or when bodyweight was added to the model creating a better fit by removing the MSD groupings.

2. In the Discussion the authors should emphasize more the possible use of other gait measuring methods.

Thank you for this comment. We have added additional detail in the discussion to include more detail on possible gait measuring methods. Please see lines 431-445 and lines 476 – 486

3. line 419: Control of the velocity is not necessarily needed if the collected intact data is sorted and characterized by that aspect. By comparing the matching MSD data, different velocities make the assessment even more precise.

Further discussion, on the utility of velocity in assessing musculoskeletal disease in cats, has been added in lines 454-455 and 482-485.

Thank you again for taking the time to review our paper. We hope this resubmission meets the required suggestions from this review process.

Yours sincerely,

Dr Nathalie Dowgray and co-authors

Attachment

Submitted filename: Cover letter Revision 2.docx

pone.0314629.s006.docx (16.5KB, docx)

Decision Letter 2

Antal Nógrádi

14 Nov 2024

Paw pressure and gait in middle-aged client-owned cats with and without naturally-occurring musculoskeletal disease

PONE-D-24-25503R2

Dear Dr. Dowgray,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Antal Nógrádi, M.D., Ph.D., D.Sc.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors have adressed all the raised questions and comments.

The manuscript in its present form is eligible for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Antal Nógrádi

21 Nov 2024

PONE-D-24-25503R2

PLOS ONE

Dear Dr. Dowgray,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Antal Nógrádi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Summary of co-efficient of variation in gait parameters from n = 31 apparently healthy middle-aged cats.

    Min = minimum value, Max = maximum value, Q1 = 1st quartile, Q3 = 3rd quartile, SD = standard deviation. Values in bold indicate distribution.

    (DOCX)

    pone.0314629.s001.docx (21.8KB, docx)
    S2 Table. Summary of co-efficient of variation in gait parameter from n = 22 middle-aged cats with musculoskeletal disease.

    Min = minimum value, Max = maximum value, Q1 = 1st quartile, Q3 = 3rd quartile, SD = standard deviation. Values in bold indicate distribution.

    (DOCX)

    pone.0314629.s002.docx (21.9KB, docx)
    S1 File. Analysis of variance (ANOVA) of peak vertical force (PVF) and vertical impulse (VI) by limb and mean palmar and plantar pressure distribution and topological t-tests for palmar and plantar pressure distribution in the paws, of 53 cats.

    (DOCX)

    pone.0314629.s003.docx (14.1MB, docx)
    S1 Data set. Raw spatiotemporal and kinetic parameters from 53 cats.

    Group = Musculoskeletal disease (MSD) or Apparently Healthy (AH), Walk = gait cycle recorded, W(N) = cats weight in newtons at time of recording, LF, RF., LH, RH indicated limb recorded. MaximunForceBW = maximum force as a % of body weight, MaximunForceN = maximum force in newtons, FTIBW = maximum vertical impulse as a % of body weight, FTIM = maximum vertical impulse in newtons, MPP = maximum peak pressure in newtons per m2, TTFI = maximum vertical impulse for all four limbs, other parameters are as outlined in Table 1 of the main manuscript.

    (XLSX)

    pone.0314629.s004.xlsx (149.8KB, xlsx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0314629.s005.docx (16.7KB, docx)
    Attachment

    Submitted filename: Cover letter Revision 2.docx

    pone.0314629.s006.docx (16.5KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES